TG THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
TG THERAPEUTICS, INC. (TGTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of -620.53 thousand shares for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2019-08-09
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2014-12-31 was 713.33K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2014 was 1.62M shares, a 208.69% increase from fiscal 2013.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2013 was 523.75K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2019-06-30 | -620.53K shares 10-Q · filed 2019-08-09 | |||
| 2014-12-31 | 713.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 1.62M shares 10-K · filed 2015-03-16 | ||
| 2014-09-30 | 903.42K shares 10-Q · filed 2014-11-14 | |||
| 2013-12-31 | 523.75K shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |